טוען...
Dielectrophoresis-based microfluidic platforms for cancer diagnostics
The recent advancement of dielectrophoresis (DEP)-enabled microfluidic platforms is opening new opportunities for potential use in cancer disease diagnostics. DEP is advantageous because of its specificity, low cost, small sample volume requirement, and tuneable property for microfluidic platforms....
שמור ב:
| הוצא לאור ב: | Biomicrofluidics |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AIP Publishing LLC
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5825230/ https://ncbi.nlm.nih.gov/pubmed/29531634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1063/1.5010158 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|